CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical and Translational Oncology

• Publication date

  2013-01-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12094-013-1005-5PMID 23359188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.

  2012cited by this paper
• miR-503 represses CUG-binding protein 1 translation by recruiting CUGBP1 mRNA to processing bodies

  2012cited by this paper
• Cost analysis of lung cancer management in South Western Sydney

  2012cited by this paper
• Molecular Predictors of Response to Chemotherapy in Non-Small Cell Lung Cancer

  2011cited by this paper
• Quality of drug information database research for clinical decision support

  2011cited by this paper
• Never smokers with lung cancer: analysis of genetic variants.

  2011cited by this paper
• CUG-binding protein represses translation of p27Kip1 mRNA through its internal ribosomal entry site

  2011cited by this paper
• Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.

  2011cited by this paper
• HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms.

  2010cited by this paper
• Analysis of CUGBP1 Targets Identifies GU-Repeat Sequences That Mediate Rapid mRNA Decay

  2010cited by this paper
• Global hemostasis in pregnancy: are we using thromboelastography to its full potential?

  2010cited by this paper
• The Classification of Lung Carcinoma: Time to Change the Morphology-Based Approach?

  2010cited by this paper
• CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.

  2010cited by this paper
• Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.

  2010cited by this paper
• The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research.

  2010cited by this paper
• The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.

  2009cited by this paper
• WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor

  2009cited by this paper
• Adjuvant treatment of resected lung cancer.

  2009cited by this paper
• PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.

  2009cited by this paper
• Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy

  2009cited by this paper
• EGFR and HER2 Genomic Gain in Recurrent Non-small Cell Lung Cancer After Surgery: Impact on Outcome to Treatment with Gefitinib and Association with EGFR and KRAS Mutations in a Japanese Cohort

  2009cited by this paper
• [Results of pneumonectomy for non-small cell lung cancer in Iceland].

  2009cited by this paper
• The Significance and Relationship between Mast Cells and Tumour Angiogenesis in Non-small Cell Lung Carcinoma

  2008cited by this paper
• The RNA-binding Protein CUGBP1 Regulates Stability of Tumor Necrosis Factor mRNA in Muscle Cells

  2008cited by this paper
• Posttranscriptional regulation of mammalian circadian clock output.

  2007cited by this paper
• Results of a prospective observational study on efficacy and safety of the TOT-SAFYRE® (TOT/S), a composite silicone-polypropylene sling system for the treatment of stress urinary incontinence (SUI)

  2006cited by this paper
• Overexpression of CUG Triplet Repeat-binding Protein, CUGBP1, in Mice Inhibits Myogenesis*

  2004cited by this paper
• Survival predictors in advanced non-small cell lung cancer.

  1995cited by this paper
• Lung Cancer 1

  1981cited by this paper

• A small interfering RNA inhibits lung fibroblast-myofibroblast differentiation via simultaneously knockingdown CELF1 and activating RIG-I signalling.

  2025cites this paper
• Small Molecule with Big Impact: Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis

  2024cites this paper
• Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review

  2024cites this paper
• CELF Family Proteins in Cancer: Highlights on the RNA-Binding Protein/Noncoding RNA Regulatory Axis

  2021cites this paper
• The RNA-binding proteins CELF1 and ELAVL1 cooperatively control RNA isoform production

  2020cites this paper
• The RNA-binding proteins CELF1 and ELAVL1 cooperatively control alternative splicing

  2018cites this paper
• Protein partners of the eEF1Bβ subunit of the translation elongation complex eEF1B in the nuclear fraction of human lung carcinoma cells

  2017cites this paper
• Orthogonal ubiquitin transfer identifies ubiquitination substrates under differential control by the two ubiquitin activating enzymes

  2017cites this paper
• Protein partners of the eEF 1 Bβ subunit of the translation elongation complex eEF 1 B in the nuclear fraction of human lung carcinoma cells

  2017cites this paper
• Post-transcriptional regulation of mPGES-1 by the balance between CUGBP1 and miR-574-5p

  2017cites this paper
• New oncogenic networks regulated by the RNA binding factor CUGBP1 in melanoma

  2016cites this paper
• Overexpression of CUGBP1 is associated with the progression of non-small cell lung cancer

  2015cites this paper
• CUG‐binding protein 1 (CUGBP1) expression and prognosis of brain metastases from non‐small cell lung cancer

  2015cites this paper
• CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1B

  2015cites this paper
• RNA-binding protein CELF1 promotes tumor growth and alters gene expression in oral squamous cell carcinoma

  2015cites this paper
• CUGBP1 promotes cell proliferation and suppresses apoptosis via down-regulating C/EBPα in human non-small cell lung cancers

  2015cites this paper
• Association of CELF2 polymorphism and the prognosis of nasopharyngeal carcinoma in southern Chinese population

  2015cites this paper
• Lentivirus-Mediated Knockdown of CUGBP1 Suppresses Gastric Cancer Cell Proliferation In Vitro

  2014cites this paper
• Si-RNA mediated knockdown of CELF1 gene suppressed the proliferation of human lung cancer cells

  2013cites this paper